Literature DB >> 8665335

Abrupt cessation of short-term continuous treatment with isosorbide dinitrate may cause a rebound increase in silent myocardial ischaemia in patients with stable angina pectoris.

S Y Martsevich1, N Koutishenko, V I Metelitsa.   

Abstract

OBJECTIVE: To examine by Holter electrocardiographic monitoring the effect of abruptly stopping nitrate treatment in patients with stable angina pectoris. PATIENTS: 12 men with confirmed ischaemic heart disease and stable exertional class 3 angina (Canadian). All had episodes of horizontal or down sloping ST segment depression during 24 hour electrocardiographic monitoring. All were nitrate responders.
DESIGN: Each patient was given isosorbide dinitrate (10-30 mg four times a day) and placebo (four times a day) for three days in a randomised crossover trial. There was a washout period of 3-5 days between the two treatment periods. Holter monitoring was performed on the third day of isosorbide dinitrate and placebo administration and on the first day of their withdrawal.
RESULTS: When treatment with isosorbide dinitrate was stopped there was a significant increase in the total number and duration of painless episodes of myocardial ischaemia. During placebo and isosorbide dinitrate administration 8 patients had episodes of painless myocardial ischaemia whereas after isosorbide dinitrate cessation they were recorded in all 12 patients. Episodes of silent myocardial ischaemia at rest appeared in 4 patients after isosorbide dinitrate withdrawal.
CONCLUSION: Abrupt cessation of short-term continuous nitrate treatment in patients with severe angina may cause a rebound increase in myocardial ischaemia which is predominantly silent.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8665335      PMCID: PMC484339          DOI: 10.1136/hrt.75.5.447

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  23 in total

1.  Silent ischemia on Holter monitoring predicts mortality in high-risk postinfarction patients.

Authors:  S O Gottlieb; S H Gottlieb; S C Achuff; R Baumgardner; E D Mellits; M L Weisfeldt; G Gerstenblith
Journal:  JAMA       Date:  1988-02-19       Impact factor: 56.272

2.  Detection and management of patients with silent myocardial ischemia.

Authors:  W B Kannel
Journal:  Am Heart J       Date:  1989-01       Impact factor: 4.749

Review 3.  Nitrate therapy in patients with coronary artery disease--preparations and doses with and without development of tolerance.

Authors:  W Rudolph; J Dirschinger; F Kraus; G Reiniger; D Hall
Journal:  Z Kardiol       Date:  1990

Review 4.  Efficacy, safety and duration of nitrate-free interval to prevent tolerance to transdermal nitroglycerin in effort angina.

Authors:  T Gumbrielle; S B Freedman; L Fogarty; S Ogasawara; P Sobb; D T Kelly
Journal:  Eur Heart J       Date:  1992-05       Impact factor: 29.983

5.  Intermittent transdermal nitroglycerin monotherapy in stable exercise-induced angina: a comparison with a continuous schedule.

Authors:  M Ferratini; S Pirelli; P Merlini; P Silva; G Pollavini
Journal:  Eur Heart J       Date:  1989-11       Impact factor: 29.983

6.  Acute and long-term effects on myocardial ischemia of intermittent and continuous transdermal nitrate therapy in stable angina.

Authors:  M Juhani Knuuti; M Wahl; I Wiklund; P Smith; L Alhainen; R Härkönen; P Puska; D Tzivoni
Journal:  Am J Cardiol       Date:  1992-06-15       Impact factor: 2.778

7.  Effect of apparent elimination half-life on nitroglycerin-induced hemodynamic rebound in experimental heart failure.

Authors:  J A Bauer; H L Fung
Journal:  Pharm Res       Date:  1993-09       Impact factor: 4.200

8.  Enhancement of the efficacy of isosorbide dinitrate by captopril in stable angina pectoris.

Authors:  V I Metelitsa; M P Kozyreva; I D Slastnikova
Journal:  Am J Cardiol       Date:  1992-02-01       Impact factor: 2.778

9.  Efficacy of continuous and intermittent transdermal treatment with nitroglycerin in effort angina pectoris: a multicentric study. The Collaborative Nitro Group.

Authors:  S Scardi; F Camerini; C Pandullo; G Pollavini
Journal:  Int J Cardiol       Date:  1991-08       Impact factor: 4.164

10.  Intermittent transdermal nitroglycerin therapy in the treatment of chronic stable angina.

Authors:  H DeMots; S P Glasser
Journal:  J Am Coll Cardiol       Date:  1989-03-15       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.